MyoPax
PrivateLast Round
Grant
Feb 20, 2025
Total Funding Raised
$7.61M
Company Overview
MyoPax is a biotechnology company developing regenerative stem cell therapies for muscle diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MyoPax Comparables
Compare MyoPax with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Myogenica, Inc. | 83% | |
| Myostellar Pty Ltd | 72% | |
| Orphina Biotechnology | 72% |
MyoPax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 20, 2025 | ||||
| Convertible Debt | Sep 5, 2022 |
MyoPax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| BioInnovation Institute | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2025
$3M grant received from European Innovation Council Fund.
- Jan 1, 2025
Co-founder lectured at the International Science Festival - Geist Heidelberg.
MyoPax Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MyoPax's valuation, stock price, and market status.
Is MyoPax a public or private company?
MyoPax is a private company.
What is the current stock price of MyoPax?
MyoPax is a private company, so its shares have no public market price. Caplight tracks MyoPax's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MyoPax worth (valuation)?
Valuation information for MyoPax is not publicly available.
Can I buy MyoPax stock?
MyoPax shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MyoPax's last funding round?
MyoPax's most recent funding round was Grant on February 20, 2025.
Who are the main investors in MyoPax?
Key investors in MyoPax include BioInnovation Institute.
Will MyoPax IPO soon?
No public IPO plans have been announced for MyoPax.
How can I track MyoPax secondary market activity?
Caplight tracks bids, offers, and trades in MyoPax's shares on secondary markets.